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Abstract.  Rotavirus  VP7 is a membrane-associated 
protein of the endoplasmic reticulum (ER). It is the 
product of rotavirus gene 9 which potentially encodes 
a protein of 326 amino acids that contains two amino 
terminal hydrophobic domains, hl and h2, each 
preceded by an initiation codon. Comparison of the 
size of products derived from altered genes containing 
coding sequences for both hl and h2 with those lack- 
ing the hl  sequence ('dhl' mutants), indicates that initi- 
ation takes place at M30 immediately preceding h2 
(residues F32 to 1-,48) and that h2 is cleaved, confirming 
the studies of others (Stirzaker,  S.  C., P.  L. Whitfeld, 
D.  L. Christie, A. R. Bellamy,  and G. W. Both.  1987. 
J.  Cell Biol.  105:2897-2903).  Our previous work had 
shown that deletions in the carboxy end of h2, extend- 
ing to amino acid 61  in the open reading frame, 
resulted in secretion of VP7.  The region from amino 
acid number 51-61, present in wild-type VP7 but 
missing in the secreted mutant A47-61,  was thus im- 
plicated to have a role in ER retention. To test this, a 
series  of chimeric genes  were constructed by fusing the 
first 63 codons of wild-type VP7,  Al-14 or A51-61/ 
dhl, to the mouse salivary ~t-amylase gene, a secretory 
protein, such that the fusion junction was located at 
the exact mature terminus of amylase. The chimeric 
proteins VP763/amylase, Al-14Jamylase and 
A51-6163/dhl/amylase were secreted when expressed in 
cells and the h2 domain was cleaved when mRNA was 
translated in vitro. These results imply that the se- 
quence 51-61 is necessary but not sufficient for ER 
retention. When a second series of VP7/amylase chi- 
mera were constructed extending the VP7 contribution 
to amino acid 111, the product expressed by AI-14HI/ 
amylase was not secreted whereas that of A47-61 ttl/ 
amylase was.  Significantly,  the intracellular 
Al-14m/amylase product exhibited an amylase enzy- 
matic specific  activity that was similar to that of the 
wild-type amylase product. We conclude that two 
regions of VP7 mediate its retention in the ER, the 
first lies within the sequence 51-61 and the second 
within the sequence 62-111, which contains the 
glycosylation site for VP7. Both regions are necessary 
for retention, though neither is sufficient alone. 
p 
ROTEINS are  targeted to various intracellular  organ- 
elles with a high degree of specificity determined in 
part by primary sequence information in proteins of 
mitochondria  (32),  the nucleus (14), or those translocated 
into the endoplasmic  reticulum  (ER) ~ (3). For several lu- 
menal  ER proteins,  the sequence  'KDEL' at the  carboxy 
terminus is necessary for their ER retention (4, 20, 24, 25) 
whereas  ER specific retention  sequence(s)  have not been 
demonstrated  for ER membrane-associated  proteins.  Viral 
protein expression systems have been useful for elucidating 
targeting behavior of proteins to the plasma membrane (1, 7, 
9) or Golgi apparatus  (21). Rotavirus provides a similarly 
useful model system for investigating membrane-associated 
proteins targeted to the ER. During the maturation of rotavi- 
rus,  virus  cores  assemble in cytoplasmic viroplasm  struc- 
tures, subsequently bud through the membranes of the rough 
1. Abbreviations used in this paper: endo-H, endo-i~-N-acetylglucosamini- 
dase H; ER, endoplasmic reticulum; wt, wild-type. 
ER or nuclear envelope and acquire a transient membrane 
envelope (8,  28,  29).  The mature double-capsid  nonenve- 
loped virions accumulate in the ER lumen.  The structural 
glycoprotein and major neutralizing antigen VP7, is initially 
a membrane-associated  protein with a lumenal orientation 
(13). VP7 exhibits only a high-mannose tbrm of carbohy- 
drate (13) consistent with its location solely in the ER (28, 
29). It is not known how VP7 assembles into virus particles 
nor by what mechanism the membrane elements are removed 
during virus maturation. 
Gene 9, which codes for VP7, has been cloned and se- 
quenced (5), and exhibits an open reading frame potentially 
encoding a protein 326 residues in length. Hydrophobicity 
analysis (17) indicates the presence of only two hydrophobic 
domains (hi  and h2) located at the amino terminus,  each 
preceded  by  an in-frame  initiation  codon,  the  second  of 
which exhibits the stronger consensus sequence for initiation 
(15, 16). Our previous studies showed that deletions at the 
COOH-terminal  end  of h2  and  the adjacent  13  residues 
© The Rockefeller  University  Press, 0021-9525/88/11/1697/10  $2.00 
The Journal  of Cell Biology,  Volume 107, November 1988 1697-1706  1697 resulted in secretion of the altered VP7's (31). More recent 
evidence (42) shows that h2 is cleaved after amino acid No. 
50,  suggesting that the distal  11 residues are significant for 
ER  retention,  rather  than  h2.  We  therefore  investigated 
whether the region of amino acids 51-61  played a  role in 
retention of VP7 in the ER, since they were present in the 
wild-type VP7 but absent in the secreted mutants A42-61, 
A43-61, or A47-61. VP7 coding sequences containing this 
11-amino acid region or those which deleted it, were attached 
to those of mature mouse salivary a-amylase, a  secretory 
protein, to assay for an effect on retention in the ER. Addi- 
tional chimera were also constructed consisting of the ma- 
ture amylase coding region and a larger contribution from 
the VP7 amino-terminal coding region of  the deletions Al-14 
and A47-61/dhl, which extended up to amino acid  111 and 
included the VP7 glycosylation site. Amylase enzymatic ac- 
tivity was similarly demonstrated for both wild-type amylase 
and  the  intracellularly retained chimera.  We  show  in  the 
present study that two regions of VP7 mediate its retention 
in the ER. The first lies within the region spanning amino 
acids 51-61 and the second in the region 62-111,  the latter 
containing the single glycosylation site for VP7. Both regions 
are apparently necessary for retention, though neither is suf- 
ficient to function by itself. 
Materials and Methods 
Construction of VP7 Mutants Lacking the First 
Initiation Codon and Hydrophobic Domain (dhl) 
Amino acids of VP7 are depicted by letter code and the various restriction 
sites used for constructing the VP7 mutants lacking the first initiation codon 
and hydrophobic domain (dhl series) or the VP7 amylase-chimeric mole- 
cules are shown (Fig. 1, A and B). The VP7 genes used in this study differed 
from the previously  published VP7 sequence  (5) at three positions,  Cys32 
to Phe, Leu~ to Phe and Thr65 to lie, and were confirmed by dideoxy  se- 
quencing (34) of our chimeric clones (see below).  VP7 mutants deleted in 
the region immediately proximal to residue 62 had Ser62 changed to Ala as 
previously  shown (31). 
The deletion of the first initiation codon, and thus its accompanying  hy- 
drophobic domain, in the constructs A42-61/dhl,  A43-61/dhl and A47-61/ 
dhl, was achieved by cutting plasmids A42-61,  A43-61  and A47-61  (31) 
with Cla  1 (New  England Biolabs,  Beverly,  MA) within the coding  se- 
quence of hl (Fig.  1). Klenow enzyme (BRL, Gaitbersburg,  MD) was then 
used to blunt the fragment ends and phosphorylated  (22) Xho I linkers (New 
England Biolabs) were added to the fragments generated.  After Xho I diges- 
tion, the 1,000- bp VP7 coding fragment was isolated for each plasmid from 
Sea Plaque low melting temperature agarose (FMC Bioproducts,  Rockland, 
ME) and cloned into the Xho I site of the expression  vector pJCll9 (36), 
after calf alkaline phosphatase treatment (Boehringer Mannheim Biochemi- 
cals,  Indianapolis,  IN) of the vector. 
Construction of  Mouse Salivary a-Amylase Vectors  for 
In Vitro Translation and In Vivo Expression Plasmids 
The plasmid pMSal04 (12) containing the full  length  cDNA coding se- 
quence of mouse salivary  a-amylase (a gift from O. Hagenbuchle,  Swiss 
Institute for Experimental  Cancer Research,  Lausanne,  Switzerland),  was 
used  in the construction of both the amylase transcription vector  Am/ 
pGEM3 (pGEM3 was obtained from Promega Biotec, Madison, WI), and 
the expression  vector pJC/Am.  The plasmid  pMSal04 was cut with Pst I 
and the 1,626-bp fragment containing the full length amylase coding region 
was isolated and cloned into the Pst I site of the pGEM3 transcription vector. 
Escherichia coli (RRI) was transformed and colonies were screened for in- 
serts as well as their orientation relative  to the SP6 or T7 promoter in 
pGEM3.  Amylase genes in the 'SP6' orientation were cut with Xho I and 
Sal I, and the resulting  1,640-bp fragment cloned into the Xho I site of 
pJCll9. Transformed colonies were screened for insert having the correct 
orientation relative to the SV40 late promoter and this plasmid was desig- 
nated pJC/Am. 
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Figure 1. Amino acid and restriction map of the 5' 
portions of VP7 and a-amylase.  The amino acid 
sequence of the first 111  residues of VP7 and the 
first 30 of a-amylase, are illustrated by letter code. 
The single glycosylation site of wild-type VP7 at 
residue 69 is depicted (CHO) as are the two hydro- 
phobic domains (h/and h2).  The various restric- 
tion sites used for creating the VP7 mutants lack- 
ing  the  first  initiation codon  (dhl  series) or  the 
VP7-amylase chimera are shown above the appro- 
priate  sequence.  The  numbers  above the  amino 
acids in the wild-type and deletions refer to the ami- 
no acid position in the wild-type sequence.  The 
deletions A51-61,  A47-61,  A43-61  and  A42-61 
each retain the coding sequence for amino acid  1 
through 50, 46, 42, or 41, respectively, and delete 
the  amino  acid  coding  sequence  specified.  The 
'dhl' counterparts of these mutants each have a non- 
coding sequence (thin lines) preceding the initiat- 
ing methionine at position 30, and the deletions of 
the amino acid coding sequences are shown (dot- 
ted lines).  The arrow beneath the wild-type amy- 
lase sequence shows the position of the cleavage 
site  for  signal  peptidase.  The  chimeric  VP7- 
amylase coding sequences consist of either a wild- 
type or altered 5' VP7 coding sequence, extending 
to either amino acid 63 or 111, joined to the amy- 
lase sequence that extends from amino acid 16 to 
its terminus (VP%3/Am,  Al-1463/Am,  A51-6163/ 
dhl/Am,  Al-14.1/Am, and A47-61m/dhl/Am). 
The Journal of Cell Biology, Volume 107, 1988  1698 Construction of VP76j-Amylase Chimera 
VP7jAm, Al-1463/Am or A51-6163/dhl/Am  expression vectors were con- 
structed by restricting the plasmids pJC9, Al-14, each previously described 
(31), or A51-61/dhl,  with Xho I and initially isolating the 1,100-bp fragment 
(reference to fragment sizes are approximate) encoding wild-type or a dele- 
tion of VP7. The 100-200-bp fragment encoding the 5' end of each of the 
three variations of VP7 was purified after Nco I digestion, and ligated to 
the large Xho I/Apa I fragment of pJC/Am (pJC/Am-sig). pJC/Am-sig was 
thus pJC/Am lacking the wild-type signal sequence coding region. Precise 
deletion of the 5' signal sequence coding region of amylase was achieved 
by Apa I restriction of pJC/Am, blunting of the end which formed the junc- 
tion between VP7 and amylase with T4 polymerase, followed by Xho I 
digestion which removed the small Xho I/Apa I fragment encoding the amy- 
lase signal but which retained the exact amino terminus of mature amylase 
(39). The VP7-amylase coding sequences were each ligated at their junc- 
tions after treatment with Klenow enzyme, which blunted the overhang left 
by Nco I digestion of VP7. 
Construction of VP7m-Amylase Chimera and 
DNA Sequencing 
The  expression vectors  Al-14m/Am  and  A47-61m/dhl/Am  were  con- 
structed by restricting the plasmids AI-14 and A47-61/dhl with Bal I and 
Xho I, isolating each 300-bp fragment which contained the respective cod- 
ing sequence of the amino terminus of VP7 including the single glycosyla- 
tion site, and then cloning each into pJC/Am-sig. 
The dideoxy method of DNA sequencing (34) was used to confirm the 
amino terminal VP7 coding sequence and the VP7-amylase  junctions for the 
constructs  A51-6163/dhl/Am,  Al-14m/Am  and  A47-61m/dhl/Am.  The 
coding sequences of the chimeric VP7-amylase molecules were each cloned 
into either pTZ18R  or pTZ19R  (Pharmacia Fine Chemicals, Piscataway, 
NJ). For A51-61jdhl/Am, this was achieved by cutting the plasmids with 
Barn HI and cloning the 1,700-hp fragment into the Barn HI site in pTZ18R. 
Xho  I/Barn  HI  fragments of Al-14m/Am  and  A47-61m/dhl/Am  were 
cloned into the Barn HI/Sal I site of pTZ19R.  JM101 or JMI09 strains of 
bacteria were transformed with the ligation mixtures and colonies were 
screened  for  inserts,  and  in  the  case  of A51-6163/dhl/Am  in  pTZ18R, 
orientation monitored by restriction enzyme analysis. The transformed bac- 
teria containing the construct in the desired orientation were infected with 
helper phage to generate single stranded DNA. Sequencing reactions used 
the T7 primer or a  synthesized primer, 5' TATAATTTATCd3ATTTCT 3' 
which annealed within the 5' terminal coding sequence of VP7, thus allow- 
ing an increased range of sequencing of the chimeric coding regions. Reac- 
tion mixtures incorporating 35S-ATP were run on acrylamide-urea gels for 
analysis. 
Construction of  pGEM3 Transcription Vectors 
Containing VP7 or VP7-Amylase Chimeric 
Coding Sequences 
Full length VP7, A47-61  or A51-61  were digested with Nhe I/Xho I and 
the resulting 1,000-bp fragment was cloned into Xba I/Sal I site ofpGEM3, 
with an orientation compatible with the T7 promoter. The A47-61/dhl and 
A51-61/dhl variations, (which served to remove the first initiation codon for 
each of these VP7 deletions), were made by digesting A47-61/pGEM3 and 
A51-61/pGEM3 with Sma I and Cla I, treating with Klenow enzyme to fill 
in the overhangs and ligating the DNA closed. Mutant Al-14 was digested 
with Xho I and the 1,000-bp fragment isolated and cloned into the Sal I site 
of pGEM3. Restriction analysis was used to select the construct with the 
insert compatible with the T7 promoter. For the construction of VP76flAm, 
Al-1463/Am  or  A51-6163/dhl/Am  chimera in  the pGEM3  transcription 
vectors, the respective plasmids were each restricted with Barn  HI,  the 
1,800-bp  piece was  isolated and  ligated to  Barn  HI  linearized pGEM3. 
Miniprep DNA restriction analysis was performed to determine if the in- 
serts were in the correct orientation for utilization of either the T7 or SP6 
promoter. For transcription of wild-type amylase, VP763/Am or A51-6163/ 
dhl/Am, the SP6 promoter orientation was used. For AI-14JAm the T7 
promoter orientation was used. 
Transcription and Translation of the VP7, Amylase or 
VP76J-Amylase Chimera  pGEM3 Constructs 
pGEM3  DNA  constructs containing wild-type VP-/,  the  VP7  deletions 
(Al-14, A47-61, A47-61/dhl, A51-61 and A51-61/dhl),  wild-type amylase, 
or the VP763-amylase  chimera, were obtained by standard bacterial lysis 
procedures and purified by precipitation or by cesium chloride-ethidium 
bromide ultracentrifugation followed by precipitation and resuspension in 
water.  Before use as a template for in vitro run off transcription, plasmid 
DNA was linearized at a suitable restriction site downstream of the 3' end 
of the DNA coding sequence of interest. After being linearized, the DNA 
was extracted one time each with phenol, phenol/chloroform (1:1), and then 
chloroform and precipitated according to usual cloning procedures (22). 
The transcription reactions were performed using the Promega Riboprobe 
Gemini System (Promega Biotec), according to the recommendations and 
procedures of the manufacturer. Briefly, for a 50-0.1 transcription mix, a 5 × 
transcription  buffer  consisting of 200  mM  Tris-HC1  pH  7.5, 30  mM 
MgCI2, 10 mM spermidine and 50 mM NaCI, was used and dithiothreitol 
(DTT) added to a final concentration of 10 mM, rNTPs were each added 
to a final concentration of 0.5 mM, 25-50 U of ribonuclease inhibitor RNa- 
sin (Promega Biotec) were added, 2-5 0`g of linearized DNA, and 10-50 
U of either Riboprobe SP6 or T7 RNA polymerase, and the reaction mix- 
ture  incubated  at  40°C  for  90  rain.  For  wild-type  amylase  the  cap 
mTG(5')ppp(5')G  (Pharmacia Fine Chemicals) was also added to a  final 
concentration of 0.5 mM. At the end of the incubation period, 3 vol of water 
and 15 lag of  yeast tRNA were added as carrier before the sample was phenol 
and chloroform extracted as above, and precipitated with ethanol and 1 M 
sodium acetate, pH 8.0. The pellet retrieved was washed in 70%  ethanol, 
dried, and then resuspended in  15-40 I11 of water. 
The message transcribed for each construct was translated using a rabbit 
reticulocyte lysate  prepared as described by  Pelham and Jackson (27). 
Rotavirus total mRNA was synthesized in an in vitro reaction taking advan- 
tage of endogenous transcription in viral cores (23). Dog pancreas micro- 
somal membranes were isolated according to the procedure of Shields and 
Blobel (35) and in vitro protein synthesis was carried out as described (35). 
Each 50-0`1 worth of reaction mixture contained 1-5 0`1 of transcribed mes- 
sage, or 0.04 A260 U of mRNA for rotavirus total message, 0.25 A280 U of 
microsomal membranes, 40  0`Ci of L[35S]methionine  and  10  0`g of calf 
liver tRNA (Boehringer Mannheim Diagnostics, Inc., Indianapolis, IN). 
The samples were incubated for 90 min at 30°C in the presence or absence 
of membranes and at the end of the incubation the samples were immuno- 
precipitated with polyclonal antiserum to VP7, described previously (31), 
or  by  rabbit anti-human salivary  ct-amylase  (Sigma Chemical Co.,  St. 
Louis,  MO).  Samples containing membranes were layered in an airfuge 
tube above a 50-0.1 cushion of 0.5 M  sucrose, 20 mM Tris-HC1,  pH 7.4, 
500 mM KCI, 2 mM CaCI2 and 5 mM MgCI2. and spun using an air pres- 
sure of 24 psi for 5 rain at 4°C. The supernatant was carefully removed and 
the membrane pellet was washed in 120 0`1 20 mM Tris-HC1,  pH 7.4,  100 
mM KCI, 2 mM CaCI2, 5 mM MgCI2, and respun in the airfuge. The su- 
pernatant was carefuly removed and the membrane pellet resuspended in 
150 0`1 of lysis buffer containing protease inhibitors, before immunoprecipi- 
tation as described previously (31). For samples that were translated in the 
absence of membranes, the reaction mixture was diluted with an equal vol- 
ume of 2×  lysis buffer,  the volume adjusted to 150 0`1 with 1x lysis buffer 
and the sample immunoprecipitated as above.  Antigen antibody complexes 
were precipitated with protein A-Sepharose CIAB (Pharmacia Fine Chemi- 
cals) and eluted from the beads by boiling in 1% SDS 0.05 M Tris,  pH 6.7, 
as described previously (31). Samples were adjusted to pH 5.0 by the addi- 
tion of  0.2 M citrate phosphate buffer, pH 5.0, and half of the samples which 
had undergone translation in the presence of membranes had 0.041  U of 
endo-I~-N-acetylglucosaminidase H  (endo-H)  (38)  added.  All  samples 
were incubated at 37°C for 1 h and then processed for analysis by SDS- 
PAGE on 10 or 11% gels (18). 
Cell Growth, Transfection, Tunicamycin Treatment, 
Radiolabeling, and lmmunoprecipitation 
COS7 cells (10) were grown and transfected as described previously (31). 
Transfected cells in 100-mm dishes were labeled with L[35S]methionine  at 
a concentration of 150-200 0`Ci/ml for 4 h at 37°C 46 h after transfection. 
Cell lysates and media were immunoprecipitated as described previously 
(31) except that either rabbit polyclonal anti-VP'/or rabbit anti-human sali- 
vary Q-amylase  antiserum was used and incubation was for 1-2 h at 4°C. 
To inhibit asparagine-linked glycosylation, cells were incubated in medium 
containing tonicamycin (Sigma Chemical Co.) at a final concentration of 5 
0`g/ml,  for 4  h before, as well as during, the 4-h labeling period, as de- 
scribed previously (31). 
To examine the kinetics of secretion of A47-61 and A47-61/dhl, trans- 
fected cells were pulsed for 15  rain at 37°C in methioniue-free medium 
containing L[3SS]methionine  at a concentration of 1 mCi/ml. Cells were 
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containing 2 mM unlabeled methionine. To compare the kinetics of secre- 
tion of deletions A47-61/dhl, pJC/Am and the chimera A47-61H  d  dhl/Am, 
transfected cells were pulsed for 10 min at 37°C in methionine-free medium 
containing L[35S]methionine at a concentration of 900 p.Ci/ml. Cells were 
rinsed after the pulse and then chased at 37°C for 1, 2, 3, or 6 h, and in 
the case of A47-61H~dhl/Am, also for 8 h, in medium containing an excess 
of unlabeled methionine as above. For analysis of Al-14m/Am, transfected 
cells were pulsed for 10 min and chased for 6 h, in the same manner. The 
chase media were collected at the given times and immunoprecipitated as 
described. The samples were applied to 11 or 12 % SDS-PAGE gels and the 
intensity of the bands corresponding to VP7, amylase, or chimera,  on the 
autoradiograph obtained were quantitated at each time point by densitome- 
try using a Quantimet 920 Image Analysis System (Cambridge Instruments, 
Inc.,  Buffalo, NY).  In another  experiment,  to  correlate  the amount  of 
intracellular wild-type amylase or Al-14m/Am product with amylase en- 
zymatic activity, equivalent dishes of cells were labeled with L[35S]methi- 
onine for 24 h at 37°C 40 h after transfection, and lysates were either used 
in an amylase assay (see below) or immunoprecipitated and analyzed on 
SDS-PAGE, autoradiographed,  and quantitated by densitometry. 
Amylase Enzymatic Assays 
A modification of the method of  assay of it-amylase described by P. Bernfeld 
(2) which measures the release of  dextrins, or maltose, from a soluble starch 
substrate at 37°C, was used to assay the enzymatic activity of lysates from 
COS7 cells which had been transfected with plasmids containing the wild- 
type  a-amylase  or the  Al-I4m/Am chimera.  Briefly, 100-mm dishes of 
COS7 cells, 48 h post-transfection, were rinsed free of medium and secreted 
products with PBS, scraped and then lysed in 1× lysis buffer (31). Volumes 
of 50,  1130, 175, or 200 I11 of lysate were each diluted to a final volume of 
250 ~tl with a buffer containing 20 mM sodium phosphate, 20 mM NaCI, 
0.2 % Triton X-100, and placed on ice. After the addition of 250 I.tl of a 1% 
soluble starch substrate made up in the same buffer, to each sample or con- 
trol tube, the samples were incubated at 30°C for 15 min before being placed 
on ice. One ml of a color reagent, consisting of 1% 3,5-dinitrosalicylic acid 
in 0.2 M potassium hydroxide and 0.021 M sodium potassium tartrate was 
added, each was boiled for 25 min, placed on ice, and then diluted with 3.5 
ml of water. The optical density of the samples was read at 520 nm and the 
values compared against a maltose standard curve prepared from 0, 5,  10, 
25,  50,  and  100-1~1 aliquots  of a  10 mg/ml  maltose  stock  solution.  An 
a-amylase  standard  curve  was obtained  by using aliquots  of a-amylase 
(Sigma Chemical Co.) in the identical assay procedure. 
Results 
Translocation and Secretion of VP7 Mutants Lacking 
the First AUG and hi 
In our previous studies  (31),  cells transfected with the dele- 
tion mutants  A42-61,  A43-61,  or A47-61,  secreted endo-H 
resistant VP7  products.  However,  since the coding regions 
for  both  initiation  codons  and  hydrophobic  domains  were 
present, it was not known from which codon initiation began 
nor which hydrophobic domain was used for translocation. 
Deletion mutants A42-61/dhl, A43-61/dhl, and A47- 61/dhl, 
each lacking the first initiation codon and thus hi, were con- 
structed in the present study to compare the products of both 
types of mutants.  COS7  cells transfected with mutants  con- 
taining either both  initiation  codons or those with only the 
second  initiation codon secreted products  of identical  size, 
indicating that the first hydrophobic domain is probably not 
normally translated  (Fig. 2,  lanes 1-12, upper and lower ar- 
rows,  glycosylated  and  unglycosylated  VP7,  respectively). 
Intracellular VP7 products also exhibited the same mobility 
whether or not the first AUG was present and were endo-H 
sensitive (data not shown). It is apparent that the mutant VP7 
proteins of the 'dhl' series were each able to use their short- 
ened h2 hydrophobic domains to target to and translocate into 
the ER. Secreted VP7 products which were glycosylated (up- 
per arrow  in Fig.  2),  were all endo-H  resistant,  consistent 
with their passage out of the ER through the Golgi apparatus 
and their modification to complex type of carbohydrate.  As 
noted previously (31),  wild-type VP7 was not secreted when 
cells were transfected with pJC9 (lanes 13 and 14). Likewise, 
nonspecific bands  in the position of VP7 were not observed 
in the media of control cells transfected with vector that did 
not  contain  insert,  pJCll9  (lanes  15  and  16). Roughly 
equivalent amounts of material were obtained from either the 
original  deletion  or  its  'dhl' counterpart  (i.e.,  A42-61  and 
Figure 2.  Secretion of VP7  mutants  encoded by 
genes having one or both initiation codons. Cells 
were  transfected  with  pJC9  (wt  VP7),  pJCll9 
(vector,  no  insert),  A42-61,  A43-61  or  A47--61 
and  their counterparts  lacking the first initiation 
codon and hydrophobic domain, A42-61/dhl, A43- 
61/dhl and A47-61/dhl. Cells were labeled for 4 h 
with L[3SS]methionine and VP7 was immunopre- 
cipitated from the media. Samples were tested for 
endo-H digestion (+ or -  lanes). Lanes//and 12, 
and 17 and 18 each have half the amount of mate- 
rial that is displayed in each of the other lanes. To- 
tal SAil-infected MA104 cell lysate (lane 19) dis- 
plays marker intracellular glycosylated VP7.  The 
lower arrow indicates the unglycosylated and the 
upper arrow the glycosylated forms of VP7 recov- 
ered from the media. (Inset) Kinetics of secreted 
A47-61  and  A47-61/dhl  VP7  products.  Trans- 
fected  cells were pulsed  for  15  min  at  37°C  in 
medium containing L[3SS]methionine at a concen- 
tration of 1 mCi/ml before being chased for 1, 2, 
or 3 h in medium containing excess unlabeled me- 
thionine.  VP7  was  immunoprecipitated  from the 
chase  media  at  the  given  times,  analyzed  by 
SDS-PAGE,  and the  intensity  of the VP7 bands 
quantitated  at  each  time  point  by  densitometry. 
Vertical scale units are arbitrary. 
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secreted  VP7  for deletions  A47-61  and  A47-61/dhl  were 
examined  in  transfected  cells  after  a  15-min  pulse  with 
L[asS]methionine  followed  by  a  1-,  2-,  or  3-h  chase  in 
medium containing 2 mM unlabeled methionine, a lag time 
of ~  30  rain  was seen for A47-61  and  A47-61/dhl  before 
secretion occurred in a  linear fashion (inset in Fig.  2). 
In  Vitro Translation 
Immunoprecipitated VP7 products translated in vitro, using 
the transcription vector pGEM3 were also compared in size. 
Translation of total viral message, in the presence of mem- 
branes, yielded a band which was similar in size to that from 
infected cells (Fig. 3, compare lanes 1 and 4). In the present 
study, the VP7 messages did not appear to be bicistronic as 
previously described by others (6). The primary translation 
product (Fig.  3,  lane 3) was slightly larger than the mem- 
brane  modified product  which  had  carbohydrate removed 
with endo-H (lane 2), likely indicating signal sequence cleav- 
age.  Wild-type VP7  made from the  in vitro transcription/ 
translation system was the same size as VP7 made from viral 
message in the case of the primary translation product (Fig. 
3, lane 3 vs. lane 7), the membrane modified product (Fig.  3, 
lane 4 vs. lane 5), or the latter treated with endo-H (Fig. 3, 
lane 2  vs.  lane 6).  When  Al-14 products were also com- 
pared,  it  was  observed that  the  glycosylated species  had 
the same mobility as VP7 in infected cells and the in vitro 
translated wild-type VP7 product.  The primary translation 
product of Al-14 (Fig. 3, lane 9) was slightly larger than the 
membrane modified product treated with endo-H (Fig.  3, 
lane  8),  and  was  identical  to  primary products  translated 
from wild-type VP7 mRNA and that of viral message. This 
also implies signal sequence cleavage of the Al-14 product 
in the presence of membranes. Since  A1-14  lacks the first 
AUG, one can conclude that VP7 produced in infected cells, 
VP7  translated  from either  total  viral message,  wild-type 
VP7 mRNA, or Al-14 mRNA, each initiate at the second 
AUG immediately preceding h2.  A  similar comparison of 
the size of deglycosylated products made in transfected cells 
or in the in vitro translation system showed that initiation and 
translation were occurring identically in both systems (data 
not shown). Within these VP7 sequences, Alaso-Glns~ occurs 
in a context of amino acid residues which form a  site with 
a  high probability of signal peptidase cleavage, as the pre- 
dictive  rules  regarding  signal  cleavage  are  applied  (39). 
Significantly,  this  site  is  absent  in  the  mutant  product  of 
A51-61/dhl.  Its primary translation product (Fig. 3, lane 12, 
upper band) is the same size as the membrane modified prod- 
uct treated with endo-H (Fig.  3,  lane 11).  Evidently the h2 
Figure  3.  In vitro translation of SAIl rotavirus, wild-type or mutant VP7 mRNA.  Total SAIl rotavirus mRNA or mRNA derived from 
the transcription of wild-type or mutant VP7 sequences cloned into the pGEM3 vector were translated in the absence (lanes 3,  7,  9,  12, 
17, 20,  and 23) or presence  of membranes and either digested with endo-H  (lanes 2,  6,  &  H,  16,  19, and 22) or not (lanes 4,  5,  10,  13, 
18,  21,  and 24) and immunoprecipitated.  The bar indicates the position of glycosylated VP7 in SAil-infected  MAI04 cells. 
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glycosylated molecule (Fig.  3,  lane 13) is larger than VP7 
found in infected cells, or that translated in vitro from wild- 
type VP7 mRNA, consistent with this conclusion. The pri- 
mary translation product showing a faster gel mobility (Fig. 
3, lane 12, lower band) probably corresponds to a product 
resulting  from downstream  initiation  of Met63 and  repre- 
sents a species probably not translocated into the lumen of 
the ER. 
In the case of A47-61, the first AUG is also apparently not 
being used for translation since the size of the primary prod- 
uct that is made in the presence of membranes, or the latter 
treated  with  endo-H,  were  identical  in  A47-61  and  in 
A47-61/dhl (Fig. 3, compare lanes 17 and 20, 18 and 21, 16 
and 19, respectively). However, proteolytic cleavage of the 
membrane modified product appears to occur since treat- 
ment with endo-H results in a product which is smaller than 
the primary translation product. If the cleavage is due to sig- 
nal peptidase, it is not obvious where it would occur since 
there  is  no  favored signal  peptidase  cleavage  site  in  the 
A47-61 which would yield a product consistent with its ap- 
parent size on the gel. 
IntraceUular Expression and Secretion of VP7, 
Amylase, and VP7~-Amylase Chimera 
The evidence that h2 is cleaved led us to more specifically 
assess the role in ER retention, of the amino acid domain 
51-61, since the absence of the coding region for these amino 
acids  was the only difference between the mutants  which 
were secreted and  wt VP7 or AI-14,  which were not se- 
creted.  The retention function of this  region of VP7  was 
tested by constructing chimera of portions of VP7 with mouse 
salivary amylase, a normally secreted glycoprotein. Genes 
for VP7/amylase,  Al-14/amylase and  A51-61/dhl/amylase, 
each consisted of VP7 sequences up to the codon for the 63rd 
amino acid of the open reading frame attached to the gene 
for amylase  lacking  its  normal  cleavable signal  sequence 
(Fig.  1).  The chimeric genes, VP763/Am,  Al-1463/Am  and 
A51-6163/dhl/Am,  which each did not include the glycosyl- 
ation site of VP7, were cloned into the transcription vector 
pGEM3 and translation products were examined in the ab- 
sence or presence of microsomes to assess signal cleavage 
in the chimeric molecules. In the absence of membranes a 
product corresponding to the size expected, for wt amylase, 
or slightly greater for the chimera VP763/Am,  Al-1463/Am 
or A51-6163/dhl/Am, ~54 kD decreased in size upon the ad- 
dition of membranes, likely indicating signal cleavage (data 
not shown). 
To determine whether VP7 sequences distal to the second 
hydrophobic domain  (h2)  extending up  to amino  acid 63 
could target the secretory protein salivary amylase to the ER, 
the VP7-amylase chimeric products expressed by transfected 
cells were examined in cell lysates and the media in the pres- 
ence and absence of  endo-H. Wild-type VP7, as shown previ- 
ously (31),  was  immunoprecipitable from intracellular ly- 
sates in an endo-H sensitive form (Fig. 4, lanes//and 12) 
but not from the media of these cells (lanes 23 and 24). On 
the other hand, when wild-type amylase (Am), or the VP7- 
amylase chimera VP763/Am,  Al-1463/Am  or A51-6163/dhl/ 
Am,  were transfected into COS7  cells, products were im- 
munoprecipitable in each case from both intracellular lysates 
(Fig. 4, lanes 1-8) and the media (Fig. 4, lanes 13-20) after 
a 4-h labeling period, and these products did not change in 
size after endo-H treatment (Fig. 4) or when transfected cells 
were grown in the presence of tunicamycin (data not shown). 
To further assess  signal  cleavage on the wt amylase or 
VP7-amylase chimera,  products were immunoprecipitated 
from transfected cells or the media with anti-amylase anti- 
body or  with  anti-VP7.  Wild-type amylase was  only im- 
munoprecipitable with anti-amylase antibody and not with 
anti-VP7 as expected (data not shown). However, for the chi- 
meric products VP763/Am and Al-1463/Am,  not only were 
the  intracellular or  secreted products  immunoprecipitable 
with anti-amylase but they were also immunoprecipitable, 
although to a lesser degree, with anti-VP7 (data not shown). 
For the chimera A51-6163/dhl/Am, intracellular and secreted 
products were only observed when anti-amylase antibody 
Figure 4.  VP763-amylase chimera are  se- 
creted. Transfected  cells were labeled for 4 h 
with L[35S]methionine  and the products im- 
munoprecipitated from the cells (I) or the 
media (M) using anti-VP7 antibody for wild- 
type VP7 (pJC9), or anti-amylase antibody 
for wild-type amylase (Am) and the VP7- 
amylase  chimera  (VP76~/Am, A1-146JAm 
or A51-6163/dhl/Am). Half of the samples 
were digested with endo-H (+ or -  lanes). 
SAil-infected MA104 ceil lysates (lanes 9, 
10, 21, and 22) display marker glycosylated 
VP7 (white  arrowhead) and endo-H treated 
VP7 (black arrowhead). The arrow marks 
the mobility of wild-type amylase and VP7- 
amylase chimera alongside the virus protein 
NCVP2 (54 kD). 
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VP7 antibody was used, since it is likely that only two amino 
acids of the VP7 sequence remain following signal cleavage 
and are  insufficient for recognition by anti-VP7  antibody. 
Taken together with the in vitro data, these results imply that 
the amino terminal hydrophobic domain of each of the three 
VP7-amylase chimera, VP763/Am,  Al-1463/Am  or A51-6163/ 
dhl/Am,  is probably removed by signal peptidase.  Though 
the protein sequence of VP7 from amino acid 51-61 is neces- 
sary for ER retention,  it is apparent that it is not sufficient 
since its presence on amylase does not prevent secretion of 
this molecule. 
IntraceUular Expression  and Secretion of 
VPTtu-Amylase  Chimera 
Additional  VP7-amylase chimera were constructed  to  de- 
termine  whether  the  VP7  sequence  spanning  amino  acid 
residues 62-111, including its single glycosylation site at resi- 
due 69, could provide an ER retention function whose pres- 
ence would be necessary to supplement the role of the region 
spanning  residues  51-61.  The  chimera  constructed  com- 
prised the 5' coding region of deletion Al-14 extending to the 
coding region of the 11 lth amino acid in the wild-type VP7 
open reading frame, or the equivalent region of A47-61/dhl 
extending to the same amino acid, each attached to the cod- 
ing sequence of amylase corresponding to the precise amino 
terminus of the mature molecule to form Al-14m/Am and 
A47--611tl/dhl/Am.  When  these  chimeric  genes  were  ex- 
pressed,  it  was  observed that  the  products  for each  were 
glycosylated, since the single VP7 glycosylation site was now 
present in the fusion protein (Fig. 5). The chimera with the 
mature wt VP7 amino terminus extending to amino acid 111 
(Al-14m/Am) was retained  intracellularly (Fig.  5),  proba- 
bly in the ER since it was endo-H sensitive (Fig. 5), whereas 
the chimera lacking the VP7 amino terminal region amino 
acids  51-61  but  retaining  amino  acids  62-111  (A47-61 m/ 
Figure 5. Chimeric protein Al-14m/amylase is not secreted where- 
as A47-61 m/dhl/amylase is secreted. Intracellular (I) and secreted 
(M) products were immunoprecipitated from cells transfected with 
either  the  Al-14m/Am or  A47-61m/dhl/Am  constructs  and  la- 
beled  for 4 h with  L[35S]methionine. The solid arrows and bars 
mark the position of the Al-14m/Am and A47-61 m/dhl/Am intra- 
cellular products, respectively, before or after (+ or -  lanes) endo- 
H treatment. The position of the secreted A47-61 m/dhl/Am prod- 
uct is indicated by the open arrow. 
Figure 6. Retention of Al-14m/amylase and secretion of A47-61m/ 
dhl/amylase  chimera  after  a  pulse-chase.  Intracellular  (1)  and 
secreted (M) products were immunoprecipitated from cells trans- 
fected  with  either  the  Al-14m/Am  or  A47-61m/dhl/Am  con- 
structs,  labeled for  10 min with LpSS]methionine and chased  in 
medium containing excess unlabeled methionine for 1, 2, 3, 6, or 
8 h (6 h for Al-14m/Am only). The proteins of the virus infected 
cell lysate serve as markers. 
dhl/Am) was secreted from the cell (Figs. 5 and 6) and ex- 
hibited endo-H resistant glycosylation (Fig. 5). These results 
along with those in  the  previous section  indicate  that  two 
regions in VP7 are necessary for ER retention, namely a seg- 
ment within the domain of amino acids 51-61  and another 
within the region 62-111. 
Kinetics of  Secretion 
A pulse-chase experiment was performed to examine the ki- 
netics of secretion of the VP7 amylase chimera and to com- 
pare it to wild-type amylase and the secreted mutant of VP7. 
When transfected cells were pulsed for 10 min with L[35S]  - 
methionine and followed by a  1-, 2-, 3-, 6-, or 8-h chase, the 
secretion kinetics of A47-61 m/dhl/Am, A47-61/dhl and wt 
amylase were compared (Figs. 6 and 7). As expected, amy- 
lase was secreted the most rapidly and efficiently. Secretion 
of the chimera was less rapid and complete (Fig.  7).  The 
half-time for secretion of amylase was about 1.5 h, whereas 
A47-61 m/dhl/Am and A47-61/dhl were each about 2.25 h, 
consistent  with  the  presence of one  of the  two  necessary 
regions  for ER retention thus  slowing down exit from the 
ER. However, even after 6 h of chase, none of the complete 
VP7  amino  terminal/amylase  chimera  (Al-14m/Am)  was 
secreted (Fig.  6),  underscoring that the amino terminal re- 
gion contains the VP7 retention domain. 
Amylase Enzymatic Assays 
To test whether the VP7-amylase chimeric product made and 
retained by cells transfected with the construct Al-14m/Am 
was indeed in a conformation which displayed amylase activ- 
ity, two enzymatic assays were performed. Lysates of COS7 
cells that were transfected with either the plasmid containing 
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Figure  7.  Kinetics of secretion of A47-61/dhl, wild-type amylase 
and  chimeric  A47-61m/dhl/Am.  Cells  transfected with  either 
A47-61/dhl, pJC/Am or A47-61  m/dhl/Am, were pulsed for 10 min 
with  L[35S]methionine and  then  chased  for 1,  2,  3,  6,  or 8 h 
(A47-61m/dhl/Am) in medium containing excess unlabeled me- 
thionine. The products were immunoprecipitated from cell lysates 
and from the media, separated by SDS-PAGE, autoradiographed, 
and the bands quantitated by densitometry (circles,  intracellular; 
squares,  media). 
the gene for wild-type amylase or the chimera Al-14m/Am 
were assayed for the release of maltose, or dextrins, due to 
the enzymatic action of a-amylase and compared with a mal- 
tose standard curve. Amylase activity was proportional to the 
amount of lysate from cells producing either wild-type amy- 
lase or the Al-14ttt/Am chimera, whereas lysate from cells 
treated with only the transfection reagents (DEAE/dextran) 
did not display any activity (Fig. 8). A second assay, where 
the amount of It-amylase activity of lysates was measured by 
determining the amount of soluble chromogen liberated by 
enzymatic hydrolysis from a Procion Yellow starch substrate 
also confirmed these results (data not shown). To check the 
relative specific activity of chimeric and wild-type amylase, 
transfected cells  were  steady  state  labeled  for 24  h  with 
L[35S]methionine  and  the  amount  of Al-14m/Am  or  wt 
amylase in equal cell numbers was determined by densitome- 
try of autoradiographs  after immunoprecipitated products 
were analyzed by SDS-PAGE. Amylase activity was deter- 
mined in a separate duplicate sample of transfected cells for 
both wt amylase or the Al-14m/Am chimera. The specific 
activity, expressed as a ratio of enzyme activity to gel band 
intensity, was 3.9  x  10 -4 for Al-14m/Am compared with 
4.2  x  10  -4 for wt amylase. The similarity in specific ac- 
tivities shows that amylase activity was proportional to the 
amount of enzyme present, whether in the chimeric or in the 
wild-type forms. 
We conclude that the retained chimeric protein was prob- 
ably not in a denatured form in the ER and exhibits a con- 
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Figure 8. Amylase enzymatic activity of 
lysates from cells transfected with wild- 
type amylase (pJC/Am) or the VP7-am- 
ylase  chimera  (Al-14m/Am).  Lysates 
were assayed for the release of maltose 
from a starch substrate due to the enzy- 
matic action of a-amylase.  This release 
was compared with a control amylase 
standard and a maltose standard curve 
(squares,  Al-14m/Am;  triangles,  pJC/ 
Am;  circles,  control,  transfection  re- 
agents only). 
formation which has functional enzymatic activity. It is ap- 
parent that the VP7  sequence from amino acids 51-111 is 
necessary and sufficient for the retention of VP7 in the ER 
and also serves to retain a normally secreted protein in this 
compartment. 
Discussion 
The data presented in this paper more accurately define the 
region of rotavirus VP7 responsible for its retention in the 
ER. In our previously published work (31) we presented evi- 
dence that deletions in portions of  the amino terminus of  VP7 
resulted in the secretion of altered molecules, apparently via 
the normal secretory pathway, including passage through the 
Golgi apparatus (see Fig. 9; wt VP7, Al-14, and A47-61). 
A major conclusion arising from our previous work was that 
the secretory pathway may be the default pathway in the ab- 
sence of specific overriding signals which target membrane 
or lumenal proteins to destinations other than the extracellu- 
lar milieu. Support for this hypothesis derived from observa- 
tions of Wieland et al.  (41) who showed that a tripeptide, 
comprising an asparagine-linked glycosylation site, could be 
glycosylated in the ER, further processed in the Golgi ap- 
paratus and rapidly secreted. Likewise, ER lumenal proteins 
characterized by the sequence 'KDEIg at their carboxy termi- 
nus were also efficiently secreted when this sequence was re- 
moved (25).  A review of the subject (30) also reaches the 
conclusion that intracellular targeting may be the result of 
specific retention signals. As described above, VP7 has two 
amino terminal hydrophobic domains (hl and h2) in the open 
reading frame. It appears from the work of others (37), and 
is confirmed by the present study, that hi is not translated in 
the bulk of VP7 in vitro or in transfected cells. The preferred 
site of initiation is at M3o immediately preceding the h2 do- 
main. h2 functions as a cleavable signal sequence (37),  an 
observation confirmed in the present work by the decrease 
in size of the product processed in the presence of mem- 
branes for the wt VP7, and may also in A47-61, A47-61/dhl 
(Fig.  2)  and  the  previously  described  deletion  mutants 
A42-61 and A43-61 (data not shown). Our previous conclu- 
sion (31) that the h2 domain itself contains the ER retention 
information must be modified, refocussing attention on the 
sequence Qs~ to G6t,  lying immediately to the carboxy ter- 
minus of h2, which also had been deleted in the secreted ver- 
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Figure 9. Summary of phenotype of wild-type VP7,  VP7 deletions 
or  VP7-Amylase chimera.  The  white bars designate  the  VP7  or 
amylase sequences and the stippled regions depict the hydrophobic 
domains hi and h2. The methionines are labeled at position 1 and 
30. The dotted lines depict the regions deleted. 
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this sequence and the appropriate sequences of the amino 
terminus of VP7 were joined to the exact mature amino ter- 
minus of  mouse salivary a-amylase, normally a secreted pro- 
tein. As shown in the present work, the presence of this se- 
quence was not sufficient to prevent the secretion of amylase 
(Fig. 4;  Al-1463/Am).  As expected, the chimera A51-6163/ 
dhl/Am was also secreted but, curiously, its signal sequence 
h2 domain was apparently cleaved (data not shown) whereas 
in A51-61/dhl (Fig.  3)  the h2 domain appeared not to be 
cleaved. The VP7 h2 cleavage site As0-Qst is not present in 
A51-61/dhl nor in A51-6163/dhl/Am.  However, at the dele- 
tion junction, R49AsoA62M63  forms a high probability signal 
peptidase cleavage site which may not be used in A51-61/dhl 
because of the proximity of the glycosylation site at N69 in 
VP7. The absence of any nearby glycosylation site in the chi- 
mera  may  allow  peptidase  activity  for  A51-6163/dhl/Am 
thereby generating  a  cleaved product.  The data  obtained 
when the expressed chimeric products were immunoprecipi- 
tated with either VP7 or amylase antiserum, add support to 
the conclusion that the signal of each chimera is cleaved. 
It was apparent from the aforementioned that the presence 
of the sequence Q51-G61 in VP7 is required for retention but 
in itself is not sufficient. When a larger portion of the VP7 
amino terminus was fused to amylase, it was found that the 
chimera was retained intracellularly, presumably in the ER 
since the asparagine-linked oligosaccharide on the VP7 por- 
tion was  in the  high-mannose  form.  The additional  VP7 
sequence (62-111)  also was not sufficient in itself to cause 
retention in  the  ER,  since the chimera  A47-61m/dhl/Am 
was also secreted (see Fig. 9). One must therefore conclude 
that two regions near the amino terminus of VP7 cooperate 
in its ER retention function. We do not know if the region 
encompassing amino acids 62-111  is part of a binding site 
or whether it acts as a 'spacer' allowing the region 51-61 to 
function. In the chimera used to demonstrate the cooperativ- 
ity of the two regions, Al-14m/Am exhibits amylase activ- 
ity at levels similar to that of the wt amylase gene expressed 
in these cells. The specific activity of the enzyme was similar 
in chimeric and wild-type products. These results indicate 
that at least the amylase portion of the chimera was in the 
correct conformation and that the reason for retention was 
not due to denaturation of the chimeric protein. 
When the kinetics of secretion of VP7 deletion mutants 
and also the VP7-amylase chimera were examined, only the 
secretion of amylase was rapid and complete. The chimera 
showed a slower turnover time of the intracellular pool and 
also a less complete turnover into the medium. The transit 
time of those molecules that were secreted was  however, 
similar (~30-45 min) for all mutants, showing that once the 
altered VP7s escape the ER their secretion is rapid. These 
data may be interpreted as a partial function of one or of the 
other of the VP7 domains in mediating an ER retention. 
The method by which VP7 is retained in the ER is un- 
resolved. Though clearly not a membrane spanning protein, 
VP7 is membrane bound (13). The mode of this attachment 
is not obvious. If an a-helical wheel (32) of the amino acid 
residues from Q51 at the mature amino terminus to Wl,  is 
constructed, a marked amphipathicity is observed with all 
the charged residues segregated to one segment of the cir- 
cumference of the wheel. Such a hydrophobic face may be 
present in the folded structure and mediate membrane at- 
tachment. The rotavirus nucleocapsid protein VP6 has been 
shown to oligomerize (11) and whether or not VP7 oligomer- 
izes is being examined.  The possibility exists that an am- 
phipathic character may influence oligomerization and play 
a role in the membrane association of VP7. The nature of the 
ER retention of the VP7 is also being investigated and pre- 
sumably involves some specific sorting feature such that the 
organelle retains its characteristic components. Such sorting 
remains an elusive problem for the retention of all types of 
ER  molecules  including  the  integral  membrane  proteins 
HMG CoA reductase (19), ribophorins (33), signal sequence 
receptor (40), ERP99 (20), adenovirus E3 (26), the lumenal 
protein of the ER disulfide isomerase esterases  (24),  and 
heavy chain binding protein (4). With respect to the latter 
class, 'KDEL', found to be necessary for targeting other pro- 
teins, is not a component of VP7 and cannot explain its ER 
retention.  There is no sequence homology with other ER 
constituents on the primary sequence level although it re- 
mains to be determined whether folded structures of ER con- 
stituents bear any resemblance to each other. 
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